This study, building on the lessons learned from the ADAPT Study; will further investigate the effectiveness and safety of a combination pharmacotherapy (XR-NTX; as Vivitrol® plus once-daily bupropion extended-release tablets) for methamphetamine use disorder.
CTN Protocol ID:
CTN-0068
Status:
Completed
ClinicalTrials.gov ID:
Principal Investigator(s)
Madhukar H. Trivedi, M.D.
Professor
University of Texas Southwestern Medical Center
Mood Disorders Research Program and Clinic
5325 Harry Hines Blvd, MC9119
Dallas, TX 75390
United States
Participating Sites
- Substance Use Research Clinic at Columbia University – New York
- Hennepin County Medical Center – Minnesota
- Behavioral Health Services – South Carolina
- Center for Neurobehavioral Research on Addiction – Texas
- UCLA Center for Behavioral and Addiction Medicine – California
- CODA, Inc. – Oregon
- Substance Use Research Unit/ SFDPH – California